| Data |
Ora |
Fonte |
Titolo |
|---|
| 12/3/2025 | 03:50 | PRNUS | Regeneron Science Talent Search 2025 Awards More Than $1.8.. |
| 12/3/2025 | 02:32 | GLOBE | Regeneron Science Talent Search 2025 Awards More Than $1.8.. |
| 10/3/2025 | 10:45 | PRNUS | REGN LAWSUIT ALERT: The Gross Law Firm Notifies Regeneron.. |
| 08/3/2025 | 19:00 | GLOBE | Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in.. |
| 06/3/2025 | 11:45 | PRNUS | Regeneron Pharmaceuticals, Inc. Class Action: The Gross Law.. |
| 03/3/2025 | 11:45 | PRNUS | Shareholders of Regeneron Pharmaceuticals, Inc. Should.. |
| 28/2/2025 | 13:00 | GLOBE | Linvoseltamab Recommended for EU Approval by the CHMP to.. |
| 27/2/2025 | 11:45 | PRNUS | Shareholders that lost money on Regeneron Pharmaceuticals,.. |
| 26/2/2025 | 13:00 | GLOBE | Odronextamab BLA Accepted for FDA Review for the Treatment.. |
| 24/2/2025 | 21:00 | GLOBE | Latest DB-OTO Results Demonstrate Clinically Meaningful.. |
| 24/2/2025 | 11:45 | PRNUS | Shareholders that lost money on Regeneron Pharmaceuticals,.. |
| 20/2/2025 | 11:45 | PRNUS | Regeneron Pharmaceuticals, Inc. Sued for Securities Law.. |
| 18/2/2025 | 06:59 | GLOBE | Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review.. |
| 13/2/2025 | 11:45 | PRNUS | The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc... |
| 11/2/2025 | 22:05 | GLOBE | Regeneron Announces Investor Conference Presentations |
| 11/2/2025 | 13:00 | GLOBE | Linvoseltamab BLA Accepted for FDA Review for the Treatment.. |
| 10/2/2025 | 11:45 | PRNUS | The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc... |
| 08/2/2025 | 23:40 | GLOBE | EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3.. |
| 08/2/2025 | 21:55 | GLOBE | Three-Year Results for EYLEA HD® (aflibercept) Injection 8.. |
| 07/2/2025 | 22:36 | EDGAR2 | Form 13F-HR - Quarterly report filed by institutional.. |
| 06/2/2025 | 11:45 | PRNUS | Class Action Filed Against Regeneron Pharmaceuticals, Inc... |
| 05/2/2025 | 15:18 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 04/2/2025 | 13:11 | EDGAR2 | Form 8-K - Current report |
| 04/2/2025 | 12:30 | GLOBE | Regeneron Reports Fourth Quarter and Full Year 2024.. |
| 03/2/2025 | 11:45 | PRNUS | Shareholders of Regeneron Pharmaceuticals, Inc. Should.. |
| 30/1/2025 | 11:45 | PRNUS | The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc... |
| 27/1/2025 | 11:45 | PRNUS | Contact The Gross Law Firm by March 10, 2025 Deadline to.. |
| 23/1/2025 | 18:02 | PRNUS | America's Top 40 High School Scientists to Compete for $1.8.. |
| 23/1/2025 | 18:00 | GLOBE | America’s Top 40 High School Scientists to Compete for $1.8.. |
| 23/1/2025 | 11:45 | PRNUS | Lost Money on Regeneron Pharmaceuticals, Inc.(REGN)? Join.. |
| 21/1/2025 | 20:35 | PRNCA | REGENERON RENFORCE SA PRÉSENCE AU CANADA EN OUVRANT SON.. |
| 20/1/2025 | 11:45 | PRNUS | Regeneron Pharmaceuticals, Inc. Class Action: The Gross Law.. |
| 16/1/2025 | 11:45 | PRNUS | The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc... |
| 13/1/2025 | 12:30 | GLOBE | Regeneron Provides Business Updates and Highlights from.. |
| 13/1/2025 | 12:15 | GLOBE | Adjuvant Libtayo® (cemiplimab) Significantly Improves.. |
| 13/1/2025 | 12:05 | GLOBE | Regeneron Collaborates with Truveta and Leading American.. |
| 13/1/2025 | 11:45 | PRNUS | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff.. |
| 07/1/2025 | 22:05 | GLOBE | Regeneron to Report Fourth Quarter and Full Year 2024.. |
| 06/1/2025 | 23:42 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:13 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:12 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:11 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:08 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:07 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:04 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 19/12/2024 | 13:00 | GLOBE | Regeneron to Advance Two Factor XI Antibodies into a Broad.. |
| 18/12/2024 | 22:03 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
